These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 38184473

  • 21. Blood transfusions during neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer may have a negative impact on overall survival.
    Rosenblatt R, Lorentzi G, Bahar M, Asad D, Forsman R, Johansson M, Shareef M, Alamdari F, Bergh A, Winqvist O, Sherif A.
    Scand J Urol; 2020 Feb; 54(1):46-51. PubMed ID: 31960752
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study.
    Hinata N, Hussein AA, George S, Trump DL, Levine EG, Omar K, Dasgupta P, Khan MS, Hosseini A, Wiklund P, Guru KA.
    BJU Int; 2017 Apr; 119(4):605-611. PubMed ID: 27743481
    [Abstract] [Full Text] [Related]

  • 25. Neoadjuvant and adjuvant treatments in muscle-invasive bladder cancer: Where are we?
    Osanto S, Álvarez Gómez de Segura C.
    Arch Esp Urol; 2020 Dec; 73(10):971-985. PubMed ID: 33269716
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Evaluation of short-term outcomes of neoadjuvant chemotherapy followed by radical cystectomy in muscle-invasive bladder cancer: a single Egyptian institution experience.
    Abdelrahman I, Aboulkassem H, Elazab A, Abdallah AY, Ismail Y, Taher M.
    J Egypt Natl Canc Inst; 2023 May 05; 35(1):13. PubMed ID: 37145329
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
    Kukreja JB, Porten S, Golla V, Ho PL, Noguera-Gonzalez G, Navai N, Kamat AM, Dinney CPN, Shah JB.
    Eur Urol Focus; 2018 Sep 05; 4(5):720-724. PubMed ID: 28753837
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pathologic and survival outcomes following radical cystectomy for "progressive" and "de novo" muscle-invasive bladder cancer: A meta-analysis stratified by neoadjuvant chemotherapy status.
    Xia L, Dadabhoy A, Wood EL, Mehta SV, Roberson DS, Guzzo TJ, Bivalacqua TJ, Daneshmand S.
    Urol Oncol; 2024 Oct 05; 42(10):333.e1-333.e13. PubMed ID: 38697874
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Downstaging and Survival Associated with Neoadjuvant Immunotherapy Before Radical Cystectomy for Muscle-invasive Bladder Cancer.
    Grassauer J, Schmidt J, Cowan A, Gilbert SM, Chakiryan NH.
    Eur Urol Oncol; 2024 Feb 05; 7(1):139-146. PubMed ID: 37453853
    [Abstract] [Full Text] [Related]

  • 36. Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA.
    Hanna N, Trinh QD, Seisen T, Vetterlein MW, Sammon J, Preston MA, Lipsitz SR, Bellmunt J, Menon M, Choueiri TK, Abdollah F.
    Eur Urol Oncol; 2018 May 05; 1(1):83-90. PubMed ID: 31100232
    [Abstract] [Full Text] [Related]

  • 37. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis.
    Bhindi B, Frank I, Mason RJ, Tarrell RF, Thapa P, Cheville JC, Costello BA, Pagliaro LC, Karnes RJ, Thompson RH, Tollefson MK, Boorjian SA.
    Eur Urol; 2017 Nov 05; 72(5):660-664. PubMed ID: 28545841
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Neoadjuvant therapy for muscle-invasive bladder cancer.
    Jain RK, Sonpavde G.
    Expert Rev Anticancer Ther; 2020 Jul 05; 20(7):603-614. PubMed ID: 32546025
    [Abstract] [Full Text] [Related]

  • 40. Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.
    Vetterlein MW, Wankowicz SAM, Seisen T, Lander R, Löppenberg B, Chun FK, Menon M, Sun M, Barletta JA, Choueiri TK, Bellmunt J, Trinh QD, Preston MA.
    Cancer; 2017 Nov 15; 123(22):4346-4355. PubMed ID: 28743155
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.